This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
SA
Not CommonVerified
Sweet Annie
Artemisia annua
Malaria and intermittent fevers in TCM for 2000 years
How does Sweet Annie work against malaria parasites?
Artemisinin, the active compound in Sweet Annie, contains an endoperoxide bridge that reacts with iron inside malaria parasites to generate free radicals. These free radicals damage parasite cell membranes and proteins, rapidly killing Plasmodium organisms at multiple life stages. The high iron concentration in infected red blood cells activates this mechanism. Evidence Level: A for artemisinin mechanism of action; Traditional use for whole herb preparations.
Does Sweet Annie interact with prescription medications?
Sweet Annie (Artemisia annua) may interact with medications metabolized by cytochrome P450 liver enzymes, potentially altering drug effectiveness. Artemisinin derivatives can prolong the QT interval, so combining with other QT-prolonging medications increases cardiac arrhythmia risk. Patients on anticoagulants, antidiabetics, or other antimalarials should consult a healthcare provider before use. Evidence Level: C for whole herb interactions; better established for pharmaceutical artemisinin derivatives.
What is the proper dosage for Sweet Annie?
Artemisinin-based therapy should only be used under medical supervision as artemisinin combination therapy (ACT) for malaria. The World Health Organization prohibits artemisinin monotherapy due to parasite resistance concerns. Traditional Chinese medicine preparations vary significantly in artemisinin content, making standardization challenging. Self-treatment for malaria is strongly discouraged. Consult a qualified healthcare provider for condition-appropriate dosing. Evidence Level: A for ACT protocols; Traditional for whole herb preparations.
Is Sweet Annie safe to take during pregnancy?
Sweet Annie (Artemisia annua) is considered unsafe during pregnancy. Artemisinin has demonstrated embryotoxic and teratogenic effects in animal studies, particularly during early pregnancy. The World Health Organization advises against artemisinin-based therapy during the first trimester unless no alternative treatment exists. Women who are pregnant, may become pregnant, or are breastfeeding should avoid this herb. Evidence Level: C for whole herb safety data.
What are the side effects of Sweet Annie?
Common side effects include nausea, vomiting, and abdominal discomfort. At very high doses or with prolonged use, neurotoxicity may occur, manifesting as dizziness, balance problems, and coordination difficulties. Artemisinin derivatives can cause QT interval prolongation, potentially leading to serious cardiac arrhythmias. Allergic reactions are possible in individuals sensitive to Asteraceae family plants. Medical supervision is essential. Evidence Level: C for whole herb; better documented for pharmaceutical derivatives.
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Artemisia annua, also known as sweet wormwood or sweet annie, is a member of the Asteraceae family used primarily for its potent antimalarial properties [PMID:16612385, PMID:40061692].
Background
Artemisia annua L. is a species of wormwood native to temperate Asia and naturalized worldwide [PMID:40061692]. It is a traditional Chinese herbal medicine used for over 2,000 years [PMID:19818170, PMID:40840727].
Traditional uses
Traditionally used in Chinese medicine to treat malaria, bacterial infections, inflammation, various cancers, parasites, intermittent fevers, bone steaming, heat/fever from exhaustion, tuberculosis, lice, wounds, scabies, and dysentery [PMID:40840727, PMID:32758647]. In Egyptian folk medicine, aerial parts are used for respiratory, digestive, and sexual dysfunctions [PMID:37127141].
Active compounds
The plant is rich in secondary metabolites including sesquiterpene lactones (notably artemisinin and its derivatives), monoterpenes, phenolic compounds, polyphenols, and quercetin [PMID:16612385, PMID:32679734, PMID:40840727]. Specific volatile compounds include artemisia ketone, trans-caryophyllene, 1,8-cineole, and camphor [PMID:35170197].
Mechanism of action
Artemisinin exhibits anti-angiogenic and growth inhibition effects, and induces apoptosis via its inherent endo-peroxidase activity [PMID:30697504]. In cancer, it modulates cell signaling pathways, induces autophagy, and impacts oxidative stress and DNA damage [PMID:39739138]. Against SARS-CoV-2, compounds like scopoletin and artemisinic acid interact with 3CLpro and Spike proteins to interfere with viral insertion and replication [PMID:37832410].
Clinical evidence
Evidence CMalaria
Artemisinin and its derivatives are highly effective against multi-drug-resistant Plasmodium spp. and are the basis for recommended artemisinin-based combination therapies (ACTs) [PMID:16612385, PMID:28837410].
Evidence CCancer
Animal experiments show artemisinin-type drugs can prevent tumor development and metastasis, but there is no conclusive proof from human trials that these benefits extend to cancer patients [PMID:40061692, PMID:29746932].
Evidence DTesticular Dysfunction (Obese Rats)
Crude leaf extract of Artemisia annua attenuated high-fat diet-induced testicular dysfunctions and improved spermatogenesis in rats [PMID:37127141].
Safety & adverse effects
Experiences with malaria treatment indicate that artemisinin-based medicines are generally well-tolerated [PMID:40061692].
Evidence summary
Strong evidence exists for the antimalarial efficacy of artemisinin (Review/C). Evidence for anticancer and other biological activities is currently based on in vitro, animal models, or reviews (C/D), with a noted lack of conclusive human clinical trial data for cancer.
PubMed sources
1.PMID: 16612385 (2006) — Production of the antimalarial drug precursor artemisinic acid in engineered yeast. · Nature
2.PMID: 35280785 (2022) — Editorial: Anticancer Potential of Artemisia annua. · Frontiers in oncology
3.PMID: 31983619 (2020) — Genetic Control of Glandular Trichome Development. · Trends in plant science
4.PMID: 18977499 (2008) — Making artemisinin. · Phytochemistry
5.PMID: 40840727 (2025) — The role and mechanism of Artemisia annua L. in cancer treatment. · Journal of ethnopharmacology
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
18.PMID: 40061692 (2024) — Unlocking the Therapeutic Benefits of Artemisia Annua: A Comprehensive Overview of its Medicinal Properties. · Journal of pharmacy & bioallied sciences
19.PMID: 30697504 (2018) — Artemisinin: A Promising Adjunct for Cancer Therapy. · Cureus
21.PMID: 35144142 (2022) — Control of resource allocation between primary and specialized metabolism in glandular trichomes. · Current opinion in plant biology
22.PMID: 33614607 (2020) — High-Level Patchoulol Biosynthesis in Artemisia annua L. · Frontiers in bioengineering and biotechnology
23.PMID: 31741871 (2019) — Potential applications of artemisinins in ocular diseases. · International journal of ophthalmology
24.PMID: 37233654 (2023) — Secondary Metabolites Isolated from Artemisia afra and Artemisia annua and Their Anti-Malarial, Anti-Inflammatory and Immunomodulating Properties-Pharmacokinetics and Pharmacodynamics: A Review. · Metabolites
25.PMID: 35170197 (2022) — Comparative Study of the Essential Oil and Hydrosol Composition of Sweet Wormwood (Artemisia annua L.) from Serbia. · Chemistry & biodiversity
26.PMID: 29187859 (2017) — A Review of Biotechnological Artemisinin Production in Plants. · Frontiers in plant science
27.PMID: 39739138 (2024) — Artemisinin's molecular symphony: illuminating pathways for cancer therapy. · Molecular biology reports
28.PMID: 35369084 (2022) — Optimization of the Artemisia Polysaccharide Fermentation Process by Aspergillus niger. · Frontiers in nutrition
29.PMID: 35566390 (2022) — Biotechnological Approaches for Production of Artemisinin, an Anti-Malarial Drug from Artemisia annua L. · Molecules (Basel, Switzerland)
30.PMID: 37832410 (2023) — Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie